- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No data
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Prevention and symptomatic treatment of allergic reactions and anaphylaxia |
|---|
|
| Anaphylaxis and Quincke oedema |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Irritability and paradoxical stimulation of the central nervous system.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Young children are in general a lot more sensitive to the toxic effects of antihistamines than adults. With classical antihistamines, reversible dyskinesia and paradoxical excitement (restlessness, sleeplessness, tremors, euphoria, nervousness and an increased tendency to convulsions) can also occur at therapeutic doses. Ataxia, restlessness, hallucinations, increased body temperature, cramps followed by coma, possibly resulting in the death are the (parasympathetic) symptoms of intoxication. Use of sedating antihistamines in children aged less than 2 years is contraindicated, given that the use of promethazine and deptropine has been linked to sudden infant death syndrome (SIDS). Caution is also needed when administering it to children with sleep apnoea in their previous history, when SIDS has occurred in the family, in children who wake up less easily and in children who are ill or dehydrated. Although there have been no properly set up and controlled studies in children, it is probable that ‘non-sedating’ antihistamines do not produce central side effects, given that the extent to which they pass the blood-CSF barrier is small to zero.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Aminoalkyl ethers | ||
|---|---|---|
| R06AA52 | ||
| R06AA02 | ||
| Substituted alkylamines | ||
|---|---|---|
| R06AB03 | ||
| Phenothiazine derivatives | ||
|---|---|---|
| R06AD01 | ||
| R06AD08 | ||
| R06AD02 | ||
| Piperazine derivatives | ||
|---|---|---|
| R06AE07 | ||
| R06AE03 | ||
| R06AE09 | ||
| R06AE05 | ||
| Other antihistamines for systemic use | ||
|---|---|---|
| R06AX18 | ||
| R06AX29 | ||
| R06AX02 | ||
| R06AX27 | ||
| R06AX26 | ||
| R06AX17 | ||
| R06AX13 | ||
| R06AX25 | ||
| R06AX28 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- Rademaker C.M.A. et al, Geneesmiddelen-Formularium voor Kinderen, 2007
- Brand PLP et al, Werkboek Kinderallergologie, VU Uitgeverij, 2006, 1e druk
- Kamps WA et al, Werkboek ondersteundende behandeling kinderoncologie, VU Uitgeverij, 2005
- American Academy of Pediatrics, Advanced Pediatric Life Support, Jones and Bartlett Publis, 2007, Revised 4th edition
- Centrafarm BV., SmPC Tavegyl 1 mg tabletten ( RVG 05621) 27-06-2021, www.geneesmiddeleninformatiebank.nl
- Gebro Pharma GmbH, SmPC Tavegyl injectievloeistof (RVG 06089) 08-12-2020, www.geneesmiddeleninformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
